Boston Scientific revenue
Boston Scientific's revenue was $20.07bn in fiscal 2025, up 19.9% on the year before. Since fiscal 2009 ($8.19bn) it has grown at a compound 5.8% a year. Over the last twelve months it was $21.07bn.
Revenue history
| Fiscal year | 2009Dec 2009 | 2010Dec 2010 | 2011Dec 2011 | 2012Dec 2012 | 2013Dec 2013 | 2014Dec 2014 | 2015Dec 2015 | 2016Dec 2016 | 2017Dec 2017 | 2018Dec 2018 | 2019Dec 2019 | 2020Dec 2020 | 2021Dec 2021 | 2022Dec 2022 | 2023Dec 2023 | 2024Dec 2024 | 2025Dec 2025 | LTMSept 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 8.2 | 7.8 | 7.6 | 7.0 | 7.1 | 7.5 | 8.1 | 9.1 | 9.0 | 9.8 | 10.7 | 9.9 | 11.9 | 12.7 | 14.2 | 16.7 | 20.1 | 21.1 |
| Growth on the year before | — | −4.7% | −2.4% | −8.7% | +1.6% | +5.5% | +8.1% | +12.5% | −0.3% | +8.6% | +9.3% | −7.7% | +19.9% | +6.7% | +12.3% | +17.6% | +19.9% | — |
| Gross profit | 5.6 | 5.2 | 5.0 | 4.9 | 5.0 | 5.2 | 5.3 | 6.0 | 6.5 | 7.0 | 7.6 | 6.4 | 8.2 | 8.7 | 9.9 | 11.5 | 13.9 | 14.6 |
| Gross margin | 68.5% | 66.7% | 65.1% | 70.4% | 70.3% | 69.3% | 65.7% | 65.7% | 71.3% | 71.4% | 71.0% | 65.0% | 68.8% | 68.8% | 69.5% | 68.6% | 69.0% | 69.1% |
Where the revenue comes from
| Region | Revenue | YoY |
|---|---|---|
| United States | $12.9B | ▲ 26.0% |
| Outside the US | $7.2B | ▲ 10.3% |
| EMEA | $3.5B | ▲ 6.9% |
| Asia Pacific | $3.1B | ▲ 14.7% |
| Emerging Markets | $3B | ▲ 11.4% |
| Latin America and Canada | $678M | ▲ 8.7% |
These categories overlap or exclude eliminations, so shares aren't shown.
From Boston Scientific's 10-K filed February 17, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.
Revenue against peers
| Company | Revenue | Growth | 3-year growth a year |
|---|---|---|---|
| Boston Scientific | $21.07bn | 8.9% | 15.3% |
| GE HealthCare | $21.64bn | 6.9% | 3.9% |
| Koninklijke Philips NV | $20.16bn | 3.4% | — |
| Stryker Corporation | $26.30bn | 7.9% | 9.8% |
| Medtronic | $37.54bn | 9.8% | 6.0% |
| Baxter International | $11.61bn | 5.3% | 0.7% |
Compare with peers
- GE HealthCare revenue
- Koninklijke Philips NV revenue
- Stryker Corporation revenue
- Medtronic revenue
- Baxter International revenue
Head to head: BSX vs GEHCBSX vs PHGBSX vs SYK
More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies